Download

Download Full Text (15.3 MB)

Contents

  • M. D. Anderson leads the fight against bone pain from metastatic cancer
  • New computer program enhances the surgeon-patient consultation
  • Bladder cancer: molecular markers may guide treatment

Creative Commons License

Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License.

Publication Date

1995

Publisher

The University of Texas MD Anderson Cancer Center

City

Houston, Texas

Keywords

Janjan, N. A. (Nora A.); Payne, Richard, 1951-; Libschitz, Herman I.; Podoloff, Donald A., 1938-; Gillis, Theresa; Yasko, Alan; Hassenbusch, Samuel; Patt, Richard B.; Hill, Stratton; Grossman, H. Barton; Hsieh, Jer-Tsong; Liebert, Monica; Kleinerman, David I; Singletary, Eva; Adsit, Karen; Patient Care Team; Neoplasm Metastasis; Cancer Pain; Clinical Trials as Topic; Radiotherapy; Pain Management; Opiate Alkaloids; Morphine; Quality of Life; Patient Education as Topic; Pain Measurement; Substance-Related Disorders; Bone Neoplasms -- secondary; Urinary Bladder Neoplasms; bladder tumor-associated antigen; Biomarkers, Tumor; Antibodies, Monoclonal; Transurethral Resection of Bladder; Cystoscopy; Antineoplastic Agents; Immunotherapy; Chemotherapy, Adjuvant; Integrin alpha6beta4; Chemoprevention; Fenretinide; Prostate-Specific Antigen; Prostatic Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; Cell Adhesion Molecules; Genes, Tumor Suppressor; Precancerous Conditions; Genetic Therapy; Breast Neoplasms; Breast Neoplasms -- surgery; Patient Education as Topic; Programmed Instructions as Topic

Disciplines

History of Science, Technology, and Medicine | Oncology

Conditions Governing Access

Open

OncoLog, Volume 40, Number 03, July-September 1995

Share

COinS